Ads
related to: multiple sclerosis treatment- Efficacy & Study Info
Read Compelling Efficacy Data &
Learn About An RMS Treatment Option
- Dosing & Initiation Info
Learn About First Dosing For
An RMS Treatment Option.
- View The Safety Profile
Read About The Safety Profile For
An RMS Treatment Option.
- Additional Studies
Read About Additional RMS Clinical
Studies On The Physician Site.
- Find HCP Support
View HCP Support & Resource
Material On Official Rx Website.
- Watch Video Content
Watch Video Content For HCPs
On RMS Treatment And Efficacy.
- Efficacy & Study Info
Search results
Multiple sclerosis is on the rise in Australia, but it's not all bad news
Medical Xpress· 8 hours agoWhile the number of people with the disease has gone up significantly in the past decade, largely...
Dealing with decline from multiple sclerosis
KTVF Fairbanks· 1 day agoMultiple Sclerosis can be a debilitating condition, especially in older adults. It occurs when the body’s immune system mistakenly attacks parts of the...
Christina Applegate’s early MS symptoms make it clear that the disease can be mistaken for everyday...
Fortune via Yahoo Finance· 10 hours agoThat's the way MS used to look. And as a professional dancer and educator, I thought that I was...
Multiple sclerosis: blood test that tracks immune response could be first step in developing better ...
The Conversation· 7 days agoThis autoimmune condition is the result of the immune system damaging parts of the nerves in the brain and spinal cord, which can lead to problems with movement, vision, balance and sensation ...
Research identifies mechanisms for selective multiple sclerosis treatment strategy
Medical Xpress· 2 days agoThe lab's findings are published in Nature Microbiology in a paper titled "Multiple sclerosis patient derived spontaneous B cells have distinct EBV and ...
First person with MS to play in the NBA shares his inspiring message: 'Make the most of it'
Fox News via Yahoo News· 20 hours agoAhead of World MS Day, former NBA player Chris Wright and his neurologist, Dr. Heidi Crayton, joined...
...Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024...
Morningstar· 3 days agoTG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of upcoming presentations highlighting study designs for post-marketing studies being undertaken for BRIUMVI® (ublituximab-xiiy ...
Sudden Hearing Loss in One Ear: What You Need to Know and How to Seek Help
Verywell Health via Yahoo News· 1 day agoSudden hearing loss in one or both ears may indicate an infection, ear wax, a tumor, a head trauma,...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 17 hours agoThis interview took place in conjunction with World MS Day, a day dedicated to raising global awareness about this debilitating disease. Vitt emphasized the significant unmet medical need for ...
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a...
Morningstar· 8 hours agoInc. (Nasdaq: BIIB) announced the European Commission (EC) has granted marketing authorization under exceptional circumstances and maintained orphan designation for QALSODY® (tofersen) for the ...